Regulation of temozolomide-induced death of glioblastoma cells: dose responses and role of HIPK2
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Mainz, Johannes Gutenberg-Universität Mainz, Dissertation, 2019
- Keyword
-
Cells
Death
- Event
-
Veröffentlichung
- (where)
-
Mainz
- (who)
-
Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
- (when)
-
2022
- Creator
- URN
-
urn:nbn:de:hebis:77-openscience-eb800087-9f0d-4ec5-9a80-d371cf04afe93
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- He, Yang
- Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
Time of origin
- 2022
Other Objects (12)
Considering the experimental use of temozolomide in glioblastoma research
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
Accelerated hyperfractionation plus temozolomide in glioblastoma
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
Acquired Temozolomide Resistance Instructs Patterns of Glioblastoma Behavior in Gelatin Hydrogels
Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide
Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line
Identification of novel NF-κB target genes mediating Smac mimetic-induced sensitization of glioblastoma cells to temozolomide-induced cell death
Considering the experimental use of temozolomide in glioblastoma research
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
Accelerated hyperfractionation plus temozolomide in glioblastoma
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
Acquired Temozolomide Resistance Instructs Patterns of Glioblastoma Behavior in Gelatin Hydrogels
Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide
Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line
Identification of novel NF-κB target genes mediating Smac mimetic-induced sensitization of glioblastoma cells to temozolomide-induced cell death
Considering the experimental use of temozolomide in glioblastoma research
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
Accelerated hyperfractionation plus temozolomide in glioblastoma
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
Acquired Temozolomide Resistance Instructs Patterns of Glioblastoma Behavior in Gelatin Hydrogels
Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide
Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line